Evidence map›Paper›PMID 33396681›Full record

ArticlePharmaceuticals (Basel, Switzerland)2020

Copper(II) and Zinc(II) Complexes with the Clinically Used Fluconazole: Comparison of Antifungal Activity and Therapeutic Potential.

Nevena Lj Stevanović, Ivana Aleksic, Jakob Kljun, Sanja Skaro Bogojevic, Aleksandar Veselinovic, Jasmina Nikodinovic-Runic, Iztok Turel, Miloš I Djuran, Biljana Đ Glišić

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Antimicrobial Peptide Synergies for Fighting Infectious Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. RSC chemical biology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Nevena Lj StevanovićDepartment of Chemistry, Faculty of Science, University of Kragujevac, R. Domanovića 12, 34000 Kragujevac, Serbia.ORCID 0000-0003-3261-478X
Ivana AleksicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.
Jakob KljunFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.ORCID 0000-0002-1986-4840
Sanja Skaro BogojevicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0001-5159-9461
Aleksandar VeselinovicDepartment of Chemistry, Faculty of Medicine, University of Niš, Blvd. Dr Zorana Djindjica 81, 18108 Niš, Serbia.
Jasmina Nikodinovic-RunicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, 11042 Belgrade, Serbia.ORCID 0000-0002-2553-977X
Iztok TurelFaculty of Chemistry and Chemical Technology, University of Ljubljana, Večna pot 113, SI-1000 Ljubljana, Slovenia.ORCID 0000-0001-6776-4062
Miloš I DjuranDepartment of Chemical and Biological Sciences, Serbian Academy of Sciences and Arts, Knez Mihailova 35, 11000 Belgrade, Serbia.
Biljana Đ GlišićDepartment of Chemistry, Faculty of Science, University of Kragujevac, R. Domanovića 12, 34000 Kragujevac, Serbia.ORCID 0000-0002-6343-8611
University of Belgrade · RSUniversity of Kragujevac · RSUniversity of Ljubljana · SISerbian Academy of Sciences and Arts · RSUniversity of Nis · RS

Funding

Javna Agencija za Raziskovalno Dejavnost RS P1-0175Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja 451-03-68/2020-14/200042Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja 451-03-68/2020-14/200122Serbian Academy of Sciences and Arts 01-2019-F65Serbian Academy of Sciences and Arts F128
6 · The paper itself

Abstract

Copper(II) and zinc(II) complexes with clinically used antifungal drug fluconazole (fcz), {[CuCl

Indexed as

anti-biofilm activityantifungal agentscopper(II) complexfluconazolezinc(II) complex

Identifiers

PMID33396681
PMCPMC7823955
OpenAlexW3117213208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.